Apolipoprotein C-II Is a Potential Serum Biomarker as a Prognostic Factor of Locally Advanced Cervical Cancer After Chemoradiation Therapy

ApoC-II could be used as a biomarker for detection in predicting and estimating the radiation treatment outcome of patients with CC.